Edit |   |
---|---|
Antigenic Specificity | Human TNFRSF25 / DR3 |
Clone | polyclonal |
Host Species | Rabbit |
Reactive Species | human, mouse |
Isotype | n/a |
Format | ion exchange purified |
Size | 0.05 mg |
Concentration | 1 mg/ml |
Applications | Immunohistochemistry (IHC - Paraffin), Immunocytochemistry (ICC), Western Blot (WB), ELISA (EIA) |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Specificity: Peptide corresponding to amino acids in extracellular domain (ED) of human DR3 precursor. Apoptosis, or programmed cell death, occurs during normal cellular differentiation and development of multicellular organisms. Apoptosis is induced by certain cytokines including TNF and Fas ligand of the TNF family through their death domain containing receptors, TNFR1 and Fas. A novel cell death receptor was recently identified by several groups independently and designated DR3, Wsl-1, Apo-3, TRAMP and LARD. The ligand for this novel death receptor has been defined as TWEAK, also termed Apo3L. |
Immunogen | Immunogen Description: Synthetic peptide from human TNFRSF25 / DR3. |
Other Names | [TNFRSF25 / DR3 (Extracellular Domain) IHC-plus; TNFRSF25; APO-3; APO3; DDR3; Death receptor 3; DR3; Death receptor beta; LARD; Protein WSL; TR3; WSL; WSL-1; WSL-LR; Apoptosis inducing receptor; TNFRSF12; WSL1; Protein WSL-1; TRAMP; Human TNFRSF25; DR3], [DR3] |
Gene, Accession # | [TNFRSF25], Gene ID: 8718, NCBI: NP_003781.1, UniProt: Q93038 |
Catalog # | MBS242166 |
Price | $660 |
Order / More Info | Human TNFRSF25 / DR3 Antibody from MYBIOSOURCE INC. |
Product Specific References | n/a |